Novo Nordisk/DKr NOVO B
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About Novo Nordisk
Novo Nordisk A/S is a global healthcare company specializing in diabetes care and hormone replacement therapies. Headquartered in Bagsværd, Denmark, the company is renowned for its insulin and GLP-1 receptor agonists for treating diabetes, as well as products for obesity care and growth hormone therapy. Established in 1923, Novo Nordisk has grown its presence worldwide, operating in numerous countries with a substantial workforce. The company leverages its scientific research capabilities to maintain a strong position in the biopharmaceutical industry, focusing heavily on innovation in chronic disease management. Its integrated supply and production facilities support its strategic emphasis on quality control and sustainable production practices.
Ticker
DKr NOVO B
Sector
Primary listing
CSE
Employees
67,900
Headquarters
Bagsvaerd, Denmark
Website
Novo Nordisk Metrics
BasicAdvanced
kr 1.3tn
10.47
kr 27.41
0.35
kr 11.70
4.08%
Price and volume
Market cap
kr 1.3tn
Beta
0.35
52-week high
kr 455.45
52-week low
kr 224.25
Average daily volume
6.2m
Dividend rate
kr 11.70
Financial strength
Current ratio
0.788
Quick ratio
0.541
Long term debt to equity
58.687
Total debt to equity
72.086
Dividend payout ratio (TTM)
42.47%
Interest coverage (TTM)
38.38%
Profitability
EBITDA (TTM)
173,876
Gross margin (TTM)
83.20%
Net profit margin (TTM)
37.20%
Operating margin (TTM)
49.25%
Effective tax rate (TTM)
21.66%
Revenue per employee (TTM)
kr 4,830,000
Management effectiveness
Return on assets (TTM)
19.25%
Return on equity (TTM)
71.40%
Valuation
Price to earnings (TTM)
10.474
Price to revenue (TTM)
3.892
Price to book
6.28
Price to tangible book (TTM)
17.44
Price to free cash flow (TTM)
41.302
Free cash flow yield (TTM)
2.42%
Free cash flow per share (TTM)
6.951
Dividend yield (TTM)
4.08%
Growth
Revenue change (TTM)
8.13%
Earnings per share change (TTM)
16.75%
3-year revenue growth (CAGR)
20.30%
10-year revenue growth (CAGR)
11.54%
3-year earnings per share growth (CAGR)
26.65%
10-year earnings per share growth (CAGR)
15.10%
3-year dividend per share growth (CAGR)
23.58%
10-year dividend per share growth (CAGR)
13.84%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs